Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
425 people get ACOR articles and Market Currents by email alert.
Get email alerts on ACOR »
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
Bullish on Acorda: New Drug Looks PromisingZacks Investment Research • Tue, Jun 23, 2009
-
Acorda Pops on Good NewsZacks Investment Research • Thu, May 7, 2009
-
-
Acorda Down on FDA DelayZacks Investment Research • Tue, Mar 31, 2009
-
-
Acorda Therapeutics: Sell or Short?Martin Roth • Mon, Oct 1, 2007 -
Loeb's Third Point LLC Lowering Its Stake in AcordaLon Juricic • Fri, May 25, 2007 -
Activist Hedge Fund Seeks Sale of AcordaCentient Biotech Investor • Sun, Feb 25, 2007 -
Acorda Therapeutics Responds to Loeb's Sale SuggestionLon Juricic • Sun, Feb 25, 2007
-
Acorda Therapeutics: Loeb's Third Point Urges Sale of CompanyLon Juricic • Fri, Feb 23, 2007
-
Eye on Acorda TherapeuticsAnthony Payne • Tue, Feb 20, 2007 -
To learn more about Seeking Alpha Pro, click here.
-
2 Buys, 1 Sell In This Year's Biotech SurgeRichard Cox • Thu, May 30 -
-
-
-
-
-
-
-
-
-
-
6 Liquid Small-Cap Healthcare Stocks Projected For Strong GrowthZetaKap • Thu, Aug 30, 2012
-
-
-
6 Analyst Backed Small Cap Biotech Stocks With Plenty Of Cash CashZetaKap • Fri, Aug 3, 2012
-
7 Fast Growing Small Cap Biotech Stocks With Analyst ConfidenceZetaKap • Fri, Jul 6, 2012
-
-
-
-
6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected GrowthZetaKap • Thu, May 24, 2012
-
Acorda Therapeutics CEO Discusses Q3 2010 - Earnings Call TranscriptMon, Nov 1, 2010
-
Acorda Therapeutics, Inc. Q2 2010 Earnings Call TranscriptTue, Aug 3, 2010
-
Acorda Therapeutics, Inc. Q1 2010 Earnings Call TranscriptFri, Apr 30, 2010
-
Acorda Therapeutics Inc. Q4 2008 Earnings Call TranscriptTue, Feb 24, 2009
-
Acorda Therapeutics, Inc., Q3 2008 Earnings Call TranscriptTue, Nov 4, 2008
-
Acorda Therapeutics, Inc. Q2 2008 Earnings Call TranscriptFri, Sep 5, 2008
-
Acorda Therapeutics Inc. Q1 2008 Earnings Call TranscriptMon, May 5, 2008
-
Acorda Therapeutics Q3 2007 Earnings Call TranscriptTue, Nov 6, 2007
-
Business Wire (May 29, 2013)
-
Business Wire (May 28, 2013)
-
Business Wire (May 20, 2013)
-
Business Wire (May 17, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 9, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 2, 2013)
-
Business Wire (Apr 25, 2013)
-
at CNBC.com (Apr 15, 2013)
-
at CNBC.com (Apr 15, 2013)
-
Business Wire (Apr 15, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Feb 25, 2013)
-
Business Wire (Feb 19, 2013)
ACOR vs. ETF Alternatives
Company Description
We are a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system. The first... More
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
- View all 1 replies
-
Michael Webb: Bacterin is definitely a Buy! Now if they could only do a better job of informing investors of how truly ground breaking their tech is.
LATEST REPLIES
-
- View all 1 replies
-
Michael Webb: Bacterin is definitely a Buy! Now if they could only do a better job of informing investors of how truly ground breaking their tech is.
-
- View all 1 replies
-
REIT: i guess worth entering a long position below 23 for a possible 10% gain, add to my watch list thanks for sharing
-
- View all 1 replies
-